Operates general hospitals offering acute care services. Provides operating and recovery rooms for surgical procedures. Now — the numbers.
The biggest line carries real weight, but it doesn’t decide everything on its own.
This is an established company with proven profits.
The market pays 15.1× for every dollar of annual profit — around what a business like this usually costs.
Against companies in its own sector, it looks cheaper than 86% of them.
Analysts' average target sits 8% above today's price.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit power and business quality lead the class.
Clearly below the class average.
The price looks reasonable next to what the company earns.
This grade is a blend: the profit side is strong, the sales tempo slow.
The stock has been running stronger than the market lately.
Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
It met or beat analyst expectations in 8 of the last 8 quarters — consistency is a promise kept.
Over the last 4 years, sales grew only 2% a year on average — the report card’s higher growth grade leans on profit power instead.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 36/100.
On our five-subject report card, THC sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”
The takeaway: THC is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.